You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

THEOPHYLLINE - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for theophylline and what is the scope of patent protection?

Theophylline is the generic ingredient in fifty-two branded drugs marketed by Fleming Pharms, Forest Labs, Sanofi Aventis Us, Graham Dm, Endo Operations, Schering, Whitby, Schwarz Pharma, Ortho Mcneil Pharm, Cent Pharms, Hospira, Inwood Labs, Sandoz, Scherer Rp, Fisons, Kv Pharm, Cenci, Lannett, Panray, Alpharma Us Pharms, Chartwell Rx, Halsey, Pharm Assoc, Precision Dose, Roxane, Taro, Wockhardt, B Braun, Baxter Hlthcare, Hospira Inc, Nostrum Labs Inc, 3M, Chartwell Molecular, Tris Pharma Inc, Ferndale Labs, Warner Chilcott, Monarch Pharms, Roerig, Pharm Res Assoc, Nostrum Pharms Llc, Able, Alembic, Amneal, Annora Pharma, Bionpharma, Glenmark Pharms Ltd, Harman Finochem, Heritage Pharma Avet, Rhodes Pharms, Strides Pharma, Teva Pharms Inc, Velzen Pharma Pvt, Zydus Lifesciences, Medicis, and Novartis, and is included in one hundred and twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for theophylline. Twenty-six suppliers are listed for this compound.

Summary for THEOPHYLLINE

US Patents:	0
Tradenames:	52
Applicants:	55
NDAs:	123
Drug Master File Entries:	36
Finished Product Suppliers / Packagers:	26
Raw Ingredient (Bulk) Api Vendors:	170
Clinical Trials:	111
Patent Applications:	6,795
Drug Prices:	Drug price trends for THEOPHYLLINE
What excipients (inactive ingredients) are in THEOPHYLLINE?	THEOPHYLLINE excipients list
DailyMed Link:	THEOPHYLLINE at DailyMed

Drug Prices for THEOPHYLLINE

See drug prices for THEOPHYLLINE

Drug Sales Revenue Trends for THEOPHYLLINE

See drug sales revenues for THEOPHYLLINE

Recent Clinical Trials for THEOPHYLLINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tanta University	N/A
LG Chem	Phase 1
Medical College of Wisconsin	Phase 1/Phase 2

See all THEOPHYLLINE clinical trials

Pharmacology for THEOPHYLLINE

Drug Class	Methylxanthine

Medical Subject Heading (MeSH) Categories for THEOPHYLLINE

Bronchodilator Agents
Phosphodiesterase Inhibitors
Purinergic P1 Receptor Antagonists
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for THEOPHYLLINE

R03DA	Xanthines
R03D	OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R	Respiratory system

US Patents and Regulatory Information for THEOPHYLLINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tris Pharma Inc	THEOPHYLLINE	theophylline	SOLUTION;ORAL	091586-001	Jun 15, 2012	AA	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cent Pharms	THEOCLEAR-100	theophylline	TABLET;ORAL	085353-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Schering	THEO-DUR	theophylline	TABLET, EXTENDED RELEASE;ORAL	086998-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ortho Mcneil Pharm	THEOPHYL-225	theophylline	TABLET;ORAL	084726-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Roerig	SUSTAIRE	theophylline	TABLET, EXTENDED RELEASE;ORAL	085665-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ortho Mcneil Pharm	THEOPHYL	theophylline	TABLET, CHEWABLE;ORAL	086506-001	Sep 12, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for THEOPHYLLINE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Monarch Pharms	QUIBRON-T/SR	theophylline	TABLET, EXTENDED RELEASE;ORAL	087563-001	Jun 21, 1983	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.